The latest research from Fore Pharma, Global Gastro-Esophageal Reflux Disease Market and Competitive Landscape – 2020, provides comprehensive insights into Gastro-Esophageal Reflux Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares. This research analyzes and forecast Gastro-Esophageal Reflux Disease market size and drug sales. It also provides insights into Gastro-Esophageal Reflux Disease epidemiology and late stage pipeline.
This research covers the following – Gastro-Esophageal Reflux Disease treatment options, Gastro-Esophageal Reflux Disease late stage clinical trials pipeline, Gastro-Esophageal Reflux Disease prevalence by countries, Gastro-Esophageal Reflux Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries. The research scope includes the countries US, Germany, France, Italy, Spain, UK, Japan, Europe, Global (G7 Countries).
Research Scope:
– Countries: US, Germany, France, Italy, Spain, UK, Japan, Europe, Global
– Gastro-Esophageal Reflux Disease pipeline: Find out drugs in clinical trials for Gastro-Esophageal Reflux Disease by development phase 3, phase 2, and phase 1, by pharmacological class and company
– Gastro-Esophageal Reflux Disease epidemiology: Find out number of patients diagnosed (prevalence) with Gastro-Esophageal Reflux Disease by countries
– Gastro-Esophageal Reflux Disease drugs: Identify key drugs marketed and prescribed for Gastro-Esophageal Reflux Disease by countries, including trade name, molecule name, and company
– Gastro-Esophageal Reflux Disease drugs sales: Find out the sales value for Gastro-Esophageal Reflux Disease drugs by countries
– Gastro-Esophageal Reflux Disease market valuations: Find out the market size for Gastro-Esophageal Reflux Disease drugs in 2019 by countries. Find out how the market advanced from 2016 and forecast to 2025
– Gastro-Esophageal Reflux Disease drugs market share: Find out the market shares for key drugs by countries
Benefits of this Research: The research helps executives to
– Evaluate commercial market opportunities for Gastro-Esophageal Reflux Disease drugs
– Synthesize insights for business development & licensing
– Track market size, competitor drug sales, market shares in Gastro-Esophageal Reflux Disease market
– Develop in-depth knowledge of competition and markets
– Analyze Gastro-Esophageal Reflux Disease drug sales data to update your brand planning trackers
– Develop tactics and strategies to take advantage of opportunities in the market
– Track Market Events and Trends and analyze key events in Gastro-Esophageal Reflux Disease market
– Develop forecast models, healthcare frameworks, or economic models
– Answer key business questions; supports decision making in R&D to long term marketing strategies
Table of Contents
1. Gastro-Esophageal Reflux Disease Treatment Options
2. Gastro-Esophageal Reflux Disease Pipeline Insights
2.1. Gastro-Esophageal Reflux Disease Phase 3 Clinical Trials
2.2. Gastro-Esophageal Reflux Disease Phase 2 Clinical Trials
2.3. Gastro-Esophageal Reflux Disease Phase 1 Clinical Trials
3. Gastro-Esophageal Reflux Disease Epidemiology Analysis by Countries
4. US Gastro-Esophageal Reflux Disease Market Insights
4.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in US
4.2. US Gastro-Esophageal Reflux Disease Market Size & Forecast
4.3. US Gastro-Esophageal Reflux Disease Drugs Sales & Forecast
4.4. US Gastro-Esophageal Reflux Disease Market Share Analysis
5. Germany Gastro-Esophageal Reflux Disease Market Insights
5.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Germany
5.2. Germany Gastro-Esophageal Reflux Disease Market Size & Forecast
5.3. Germany Gastro-Esophageal Reflux Disease Drugs Sales Forecast
5.4. Germany Gastro-Esophageal Reflux Disease Market Share Analysis
6. France Gastro-Esophageal Reflux Disease Market Insights
6.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in France
6.2. France Gastro-Esophageal Reflux Disease Market Size & Forecast
6.3. France Gastro-Esophageal Reflux Disease Product Sales Forecast
6.4. France Gastro-Esophageal Reflux Disease Market Share Analysis
7. Italy Gastro-Esophageal Reflux Disease Market Insights
7.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Italy
7.2. Italy Gastro-Esophageal Reflux Disease Market Size & Forecast
7.3. Italy Gastro-Esophageal Reflux Disease Product Sales Forecast
7.4. Italy Gastro-Esophageal Reflux Disease Market Share Analysis
8. Spain Gastro-Esophageal Reflux Disease Market Insights
8.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Spain
8.2. Spain Gastro-Esophageal Reflux Disease Market Size & Forecast
8.3. Spain Gastro-Esophageal Reflux Disease Product Sales Forecast
8.4. Spain Gastro-Esophageal Reflux Disease Market Share Analysis
9. UK Gastro-Esophageal Reflux Disease Market Insights
9.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in UK
9.2. UK Gastro-Esophageal Reflux Disease Market Size & Forecast
9.3. UK Gastro-Esophageal Reflux Disease Product Sales Forecast
9.4. UK Gastro-Esophageal Reflux Disease Market Share Analysis
10. Europe Gastro-Esophageal Reflux Disease Market Insights
10.1. Europe Gastro-Esophageal Reflux Disease Market Size & Forecast
10.2. Europe Gastro-Esophageal Reflux Disease Product Sales Forecast
10.3. Europe Gastro-Esophageal Reflux Disease Market Share Analysis
11. Japan Gastro-Esophageal Reflux Disease Market Insights
11.1. Marketed Drugs for Gastro-Esophageal Reflux Disease in Japan
11.2. Japan Gastro-Esophageal Reflux Disease Market Size & Forecast
11.3. Japan Gastro-Esophageal Reflux Disease Product Sales Forecast
11.4. Japan Gastro-Esophageal Reflux Disease Market Share Analysis
12. Global Gastro-Esophageal Reflux Disease Market Insights
12.1. Global Gastro-Esophageal Reflux Disease Market Size & Forecast
12.2. Global Gastro-Esophageal Reflux Disease Product Sales Forecast
12.3. Global Gastro-Esophageal Reflux Disease Market Share Analysis
13. Research Methodology
List of Tables
1: Gastro-Esophageal Reflux Disease Phase 3 Clinical Trials, Global, 2020
2: Gastro-Esophageal Reflux Disease Phase 2 Clinical Trials, Global, 2020
3: Gastro-Esophageal Reflux Disease Phase 1 Clinical Trials, Global, 2020
4: Gastro-Esophageal Reflux Disease Prevalence by Countries, 2016 – 2025
5: Marketed Drugs for Gastro-Esophageal Reflux Disease in US, 2019
6: US Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
7: US Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
8: US Gastro-Esophageal Reflux Disease Market Events and Trends, 2016 – 2025
9: Marketed Drugs for Gastro-Esophageal Reflux Disease in Germany, 2019
10: Germany Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
11: Germany Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
12: Germany Gastro-Esophageal Reflux Disease Market Events and Trends, 2016 – 2025
13: Marketed Drugs for Gastro-Esophageal Reflux Disease in France, 2019
14: France Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
15: France Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
16: France Gastro-Esophageal Reflux Disease Market Events and Trends, 2016 – 2025
17: Marketed Drugs for Gastro-Esophageal Reflux Disease in Italy, 2019
18: Italy Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
19: Italy Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
20: Italy Gastro-Esophageal Reflux Disease Market Events and Trends, 2016 – 2025
21: Marketed Drugs for Gastro-Esophageal Reflux Disease in Spain, 2019
22: Spain Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
23: Spain Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
24: Spain Gastro-Esophageal Reflux Disease Market Events and Trends, 2016 – 2025
25: Marketed Drugs for Gastro-Esophageal Reflux Disease in UK, 2019
26: UK Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
27: UK Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
28: UK Gastro-Esophageal Reflux Disease Market Events and Trends, 2016 – 2025
29: Europe Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
30: Europe Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
31: Marketed Drugs for Gastro-Esophageal Reflux Disease in Japan, 2019
32: Japan Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
33: Japan Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
34: Japan Gastro-Esophageal Reflux Disease Market Events and Trends, 2016 – 2025
35: Global Gastro-Esophageal Reflux Disease Market Size & Forecast ($mn), 2016 – 2025
36: Global Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
List of Figures
1: Gastro-Esophageal Reflux Disease Pipeline by Phase (%), Global, 2020
2: Gastro-Esophageal Reflux Disease Prevalence by Countries, 2016 – 2025
3: US Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
4: US Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
5: US Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
6: US Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
7: Germany Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
8: Germany Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
9: Germany Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
10: Germany Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
11: France Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
12: France Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
13: France Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
14: France Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
15: Italy Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
16: Italy Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
17: Italy Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
18: Italy Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
19: Spain Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
20: Spain Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
21: Spain Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
22: Spain Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
23: UK Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
24: UK Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
25: UK Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
26: UK Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
27: Europe Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
28: Europe Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
29: Europe Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
30: Europe Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
31: Japan Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
32: Japan Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
33: Japan Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
34: Japan Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
35: Global Gastro-Esophageal Reflux Disease Market Size ($mn), 2016 – 2025
36: Global Gastro-Esophageal Reflux Disease Product Sales ($mn), 2016 – 2025
37: Global Gastro-Esophageal Reflux Disease Market Share by Drugs (%), 2019
38: Global Gastro-Esophageal Reflux Disease Market – Future Market Share (%), 2025
Format
Dispatch format is XLSX.